

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.
You can purchase shares of Pulmonx (NASDAQ:LUNG) through any online brokerage.
Other companies in Pulmonx’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Pulmonx has a consensus price target of $6.21.
The stock price for Pulmonx (NASDAQ: LUNG) is $1.83 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Pulmonx.
Pulmonx does not have any upcoming earnings scheduled.
There is no upcoming split for Pulmonx.
Pulmonx is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr...